Semaglutide works by mimicking a gut hormone that controls appetite, blood sugar, and digestion, and most people notice reduced hunger within the first few weeks. But the full experience unfolds over months, with a gradual dose increase, predictable side effects, and weight loss that follows a distinct pattern. Here’s what the process actually looks like from start to finish.
How Semaglutide Works in Your Body
Your gut naturally produces a hormone called GLP-1 after you eat. It signals your brain that you’re full, tells your pancreas to release insulin, and slows digestion so food stays in your stomach longer. Semaglutide is a synthetic version of that hormone, designed to last much longer than the natural one.
By activating the same receptors, semaglutide does three things simultaneously. It enhances insulin release (only when your blood sugar is elevated, which is why it rarely causes dangerous blood sugar drops on its own). It suppresses glucagon, a hormone that tells your liver to dump stored sugar into your bloodstream. And it slows gastric emptying, meaning food moves through your stomach more gradually. That last effect is a big part of why you feel full sooner, stay full longer, and simply think about food less often.
The Dose Escalation Schedule
You don’t start at the full dose. The standard schedule for the weight management version ramps up over about four months:
- Weeks 1 through 4: 0.25 mg once weekly
- Weeks 5 through 8: 0.5 mg once weekly
- Weeks 9 through 12: 1 mg once weekly
- Weeks 13 through 16: 1.7 mg once weekly
- Week 17 onward: 2.4 mg once weekly (maintenance dose)
This gradual ramp exists entirely to manage side effects. Each dose increase can bring a temporary wave of nausea as your body adjusts. Some providers will hold a patient at a lower dose for an extra few weeks if side effects are too uncomfortable before moving up. The first month at 0.25 mg is essentially a “get your body used to it” phase, and many people notice only mild appetite changes during that time.
What Weight Loss Looks Like Over Time
Weight loss on semaglutide isn’t instant, but it is steady. In the landmark STEP 1 clinical trial, patients lost roughly 2% of their body weight per month for the first six months. After that, the rate slowed to about 1% per month as the body adjusted. By week 16, participants had lost around 12% of their starting weight. By week 68 (about 16 months), average total weight loss reached 15 to 16%.
For someone starting at 220 pounds, that translates to roughly 33 to 35 pounds over a little more than a year. The losses tend to be front-loaded. You’ll likely see the most dramatic changes in the first four to six months, with slower, more incremental progress after that. Plateaus are normal and don’t mean the medication has stopped working. Your body is recalibrating its set point, and weight loss often resumes after a few weeks of stalling.
Common Side Effects and How to Handle Them
Gastrointestinal side effects are by far the most common experience. Nausea tops the list, followed by diarrhea, constipation, and occasional heartburn. These symptoms tend to peak during the first few days after each dose increase and then fade as your body adjusts over one to two weeks. For most people, they become manageable or disappear entirely by the time they reach the maintenance dose.
What you eat makes a significant difference. Fried foods, anything high in saturated fat, spicy dishes, and acidic foods are more likely to trigger nausea and heartburn while on semaglutide. The medication already slows your digestion, so heavy meals sit in your stomach much longer than they used to. When nausea hits, bland, low-fat foods like crackers, toast, rice, soups, and gelatin tend to be the easiest to tolerate.
Portion size matters too. A practical strategy is to serve yourself half of what you’d normally eat, eat slowly, and then wait 15 to 20 minutes after finishing before deciding if you want more. This prevents the uncomfortable “overfull” sensation that many people describe early on, where eating even a moderate amount can feel like finishing a Thanksgiving dinner.
Blood Sugar and Heart Health Benefits
Semaglutide was originally developed for type 2 diabetes, and its blood sugar effects are significant. In real-world data from patients on the 1 mg weekly dose, average A1C dropped by 1.2 percentage points. Patients who stayed consistent with treatment saw an even larger reduction of 1.4 percentage points. To put that in perspective, an A1C drop of 1% or more is considered clinically meaningful and typically moves someone from “poorly controlled” to “well managed” territory.
The cardiovascular benefits extend beyond blood sugar. The SELECT trial, which followed over 17,600 patients with established heart disease and obesity, found that semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) by 20%. This was in patients without diabetes, meaning the heart benefits aren’t just a side effect of better blood sugar control. They appear to come from the medication’s effects on inflammation, blood vessel function, and weight loss itself.
Giving Yourself the Injection
Semaglutide is a once-weekly injection given just under the skin. You can inject in your abdomen, thigh, or upper arm. The needle is small, similar to what people with diabetes use for insulin, and most people describe it as a quick pinch rather than anything painful. Rotate your injection site each week within the same body region to avoid skin irritation.
Before first use, the pen needs to be stored in the refrigerator between 36°F and 46°F. Once you’ve used it for the first time, it can stay at room temperature (up to 86°F) or in the fridge for up to 56 days. Never freeze it. If the pen has been frozen, it needs to be discarded. Most people pick a consistent day of the week for their injection. It doesn’t need to be the same time of day, but keeping the day consistent helps build the habit.
Serious Risks to Be Aware Of
Semaglutide carries an FDA boxed warning related to thyroid tumors. In animal studies, the drug caused a type of thyroid cancer called medullary thyroid carcinoma. It hasn’t been confirmed whether this risk applies to humans, but anyone with a personal or family history of medullary thyroid cancer or a condition called multiple endocrine neoplasia syndrome type 2 should not take semaglutide.
Pancreatitis (inflammation of the pancreas) is another known risk. Symptoms include severe, persistent abdominal pain that may radiate to your back, often accompanied by vomiting. If you experience this kind of pain, it warrants immediate medical attention. Gallbladder problems, including gallstones, have also been reported, particularly during periods of rapid weight loss. Symptoms like sharp pain in the upper right abdomen, especially after meals, shouldn’t be ignored.
What Happens If You Stop
This is perhaps the most important thing to understand going in. Semaglutide manages appetite and metabolism while you’re taking it. When you stop, those effects fade. A 2025 systematic review published in The BMJ found that people regained an average of 9.9 kg (about 22 pounds) within the first year after stopping newer medications like semaglutide. The projected timeline for returning to baseline weight was approximately 1.5 years after stopping.
This doesn’t mean the medication “failed.” It means semaglutide works more like blood pressure medication than like an antibiotic. It treats an ongoing condition rather than curing it. Many providers now frame this as long-term or indefinite therapy, with the understanding that the lifestyle changes you build while on the medication (smaller portions, more movement, different food choices) can blunt some of the rebound, even if they can’t fully prevent it. Going in with realistic expectations about this helps you plan for the long term rather than viewing it as a short-term fix.